Gestational diabetes mellitus - A metabolic and reproductive disorder.
Choudhury AA, Devi Rajeswari V.
Biomed Pharmacother. 2021 Nov;143:112183. doi: 10.1016/j.biopha.2021.112183. Epub 2021 Sep 21.
Cutaneous Manifestations of Diabetes Mellitus: A Review.
Lima AL, Illing T, Schliemann S, Elsner P.
Am J Clin Dermatol. 2017 Aug;18(4):541-553. doi: 10.1007/s40257-017-0275-z.
Clinically relevant experimental rodent models of diabetic foot ulcer.
Rai V, Moellmer R, Agrawal DK.
Mol Cell Biochem. 2022 Apr;477(4):1239-1247. doi: 10.1007/s11010-022-04372-w. Epub 2022 Jan 28.
[Type 2 diabetes complications].
Schlienger JL.
Presse Med. 2013 May;42(5):839-48. doi: 10.1016/j.lpm.2013.02.313. Epub 2013 Mar 23.
Polypharmacy is Associated with Diabetic Foot Ulcers in Type 2 Diabetes mellitus.
Imre E, Imre E.
Int J Low Extrem Wounds. 2025 Jun;24(2):320-328. doi: 10.1177/15347346221090756. Epub 2022 Mar 23.
Novel epigenetic-sensitive clinical challenges both in type 1 and type 2 diabetes.
Sommese L, Benincasa G, Lanza M, Sorriento A, Schiano C, Lucchese R, Alfano R, Nicoletti GF, Napoli C.
J Diabetes Complications. 2018 Nov;32(11):1076-1084. doi: 10.1016/j.jdiacomp.2018.08.012. Epub 2018 Aug 19.
Prevalence of diabetic foot syndrome amongst population with type 2 diabetes in Pakistan in primary care settings.
Khan A, Junaid N.
J Pak Med Assoc. 2017 Dec;67(12):1818-1824.
La nécrobiose lipoïdique: à propos d’un cas: Necrobiosis lipoidica: about a case.
Haddad NE, Ouahabi HE.
Pan Afr Med J. 2018 Jan 3;29:5. doi: 10.11604/pamj.2018.29.5.14226. eCollection 2018.
Machine learning models for diabetic neuropathy diagnosis using microcirculatory parameters in type 2 diabetes patients.
Zhang X, Sun Y, Ma Z, Lu L, Li M, Ma X.
Int Angiol. 2023 Jun;42(3):191-200. doi: 10.23736/S0392-9590.23.05008-3.
Microbiological Etiology of Chronic Skin Lesions in Type 2 Diabetic Subjects.
Chisari G, Chisari LM, Borzì AM, Luca S, Grasso A, Chisari CG.
Infect Disord Drug Targets. 2019 May 16;19(2):207-212. doi: 10.2174/1871526518666180411095823.
